Use of protein cbp2 as a marker for colorectal cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01)

Patent

CA 2565405

The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein CBP2 (collagen-binding protein 2) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring CBP2 in said sample. Measurement of CBP2 can, e.g., be used in the early detection or diagnosis of colorectal cancer.

La présente invention concerne un procédé pour diagnostiquer un cancer colorectal. Elle concerne l'utilisation d'une protéine CBP2 (protéine 2 se liant au collagène) pour diagnostiquer un cancer colorectal à partir d'un échantillon de liquide prélevé chez un individu, en mesurant CBP2 dans ledit échantillon. La mesure de CBP2 peut par exemple être utilisée pour la détection précoce ou le diagnostic d'un cancer colorectal.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of protein cbp2 as a marker for colorectal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of protein cbp2 as a marker for colorectal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of protein cbp2 as a marker for colorectal cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2001059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.